MAP-30

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMAP-30
Drug Alias NameMAP-30
ClassificationNatural product/ExtractBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHSV replication inhibitorsHIV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpesvirus type 8 infectionNeoplasmsHerpes Simplex +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNew York University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNew York University
Active IndicationsN/A
Inactive IndicationsHerpesvirus type 8 infectionNeoplasmsHerpes Simplex +[4] 

Other Information

ATC CodeN/A
Related LinksN/A